HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

BE-32030 A, B, C, D and E, new antitumor substances produced by Nocardia sp. A32030.

Abstract
New antitumor substances, designated BE-32030A, B, C, D and E, were isolated from the culture broth of Nocardia sp. A32030. The active principles were extracted from the mycelium by methanol and purified by Sephadex LH-20 and reversed-phase column chromatographies and finally by reversed-phase HPLC. BE-32030A, B, C, D and E inhibited the growth of P388 murine leukemia, DLD-1 human colon cancer, PC-13 human lung cancer and MKN-45 human stomach cancer cell lines.
AuthorsM Tsukamoto, K Murooka, S Nakajima, S Abe, H Suzuki, K Hirano, H Kondo, K Kojiri, H Suda
JournalThe Journal of antibiotics (J Antibiot (Tokyo)) Vol. 50 Issue 10 Pg. 815-21 (Oct 1997) ISSN: 0021-8820 [Print] England
PMID9402985 (Publication Type: Journal Article)
Chemical References
  • Antibiotics, Antineoplastic
  • Azepines
  • BE 32030A
  • BE 32030B
  • BE 32030C
  • BE 32030D
  • BE 32030E
  • Oxazoles
Topics
  • Animals
  • Antibiotics, Antineoplastic (chemistry, metabolism, pharmacology)
  • Azepines (chemistry, metabolism, pharmacology)
  • Drug Screening Assays, Antitumor
  • Fermentation
  • Humans
  • Mice
  • Molecular Structure
  • Nocardia (chemistry, metabolism)
  • Oxazoles (chemistry, metabolism, pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: